首页 > 最新文献

Arquivos de Gastroenterologia最新文献

英文 中文
THE BRAZILIAN BLUE MARCH CAMPAIGN. 巴西蓝色征程运动。
Q2 Medicine Pub Date : 2024-03-04 eCollection Date: 2024-01-01 DOI: 10.1590/S0004-2803.246102024-01
Marcelo Averbach, Hélio Moreira Junior, Herbeth José Toledo Silva, Francisco Sérgio Rangel de Paula Pessoa
{"title":"THE BRAZILIAN BLUE MARCH CAMPAIGN.","authors":"Marcelo Averbach, Hélio Moreira Junior, Herbeth José Toledo Silva, Francisco Sérgio Rangel de Paula Pessoa","doi":"10.1590/S0004-2803.246102024-01","DOIUrl":"10.1590/S0004-2803.246102024-01","url":null,"abstract":"","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e24001"},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HOSPITALIZATION, USE OF BIOLOGICS AND SURGERY RATES IN INFLAMMATORY BOWEL DISEASES: A SINGLE-CENTRE COMPARATIVE ANALYSIS BETWEEN PUBLIC AND PRIVATE HEALTHCARE SYSTEMS IN A TERTIARY UNIT FROM LATIN AMERICA. 炎症性肠病的住院率、生物制剂使用率和手术率:拉丁美洲一家三级医院的公立和私立医疗系统之间的单中心比较分析。
Q2 Medicine Pub Date : 2024-03-04 eCollection Date: 2024-01-01 DOI: 10.1590/S0004-2803.24612023-140
Patrícia Zacharias, Daniéla Oliveira Magro, Milena Perussolo, Fernanda da Silva Barbosa Baraúna, Paulo Gustavo Kotze

Background: Inflammatory bowel diseases (IBD) have rising incidence and prevalence rates globally. In IBD, there are scarce stu-dies comparing differences between patients according to socioeconomic status. Our aim was to comparatively evaluate hospitalizations, use of biologics and rates of surgery in patients with IBD between public and private healthcare systems.

Methods: Single-center retrospective cohort study in patients with IBD from a tertiary referral unit from Latin America, between 2015 and 2021. CD and UC patients were classified into two subgroups: public and private systems. Demographic characteristics, hospitalizations, need for surgery and biologics were compared.

Results: A total of 500 patients were included, 322 with CD and 178 with UC. CD-related hospitalizations were frequently observed in both healthcare systems (76.28% in private and 67.46% in public). More than half of the patients had been submitted to one or more CD-related abdominal surgery, with no significant difference between the subgroups. Although there was no difference in the rates of use of biological therapy in CD subgroups, infliximab was more used in the public setting (57.69% vs 43.97%). There was no difference in UC-related hospitalizations between the subgroups (public 30.69% and private 37.66%) as well as the rates of colectomy (public: 16.83%, private: 19.48%). Biologics were prescribed almost twice as often in private as compared to public (45.45 vs 22.77%).

Conclusion: There were no differences in the rates of hospitalization and abdominal surgery between the systems. In patients with UC, there was greater use of biological therapy in the private healthcare setting.

Background: • In a tertiary IBD center in Latin America.

Background: • More than half of the patients had been submitted to one or more CD-related abdominal surgical procedure.

Background: • Between the two healthcare systems, there was no difference in the rates of use of biological therapy in patients with CD, and in UC-related hospitalizations.

Background: • Biologics were prescribed almost twice as often in the private system as compared to the public in patients with UC.

背景:在全球范围内,炎症性肠病(IBD)的发病率和流行率不断上升。关于 IBD,很少有研究比较不同社会经济地位的患者之间的差异。我们的目的是比较评估公立和私立医疗系统中 IBD 患者的住院率、生物制剂使用率和手术率:单中心回顾性队列研究:2015 年至 2021 年期间,拉丁美洲一家三级转诊机构的 IBD 患者。CD和UC患者被分为两个亚组:公立和私立系统。比较了人口统计学特征、住院情况、手术需求和生物制剂:共纳入 500 名患者,其中 CD 患者 322 名,UC 患者 178 名。在两个医疗系统中,与 CD 相关的住院治疗都很常见(私立医疗系统为 76.28%,公立医疗系统为 67.46%)。半数以上的患者接受过一次或多次与 CD 相关的腹部手术,但两个亚组之间没有明显差异。虽然 CD 亚组使用生物疗法的比例没有差异,但公立医院使用英夫利西单抗的比例更高(57.69% 对 43.97%)。不同亚组的 UC 相关住院率(公立 30.69% 和私立 37.66%)以及结肠切除率(公立 16.83%,私立 19.48%)均无差异。与公立医院相比,私立医院开具生物制剂处方的频率几乎是公立医院的两倍(45.45% 对 22.77%):结论:不同系统的住院率和腹部手术率没有差异。在 UC 患者中,私立医疗机构使用生物疗法的比例更高:- 背景:拉丁美洲的一家三级 IBD 中心:- 背景:超过一半的患者接受过一次或多次与 CD 相关的腹部手术:- 在两个医疗系统中,CD患者使用生物制剂治疗的比例和UC相关住院治疗的比例没有差异:- 与公立医疗系统相比,私立医疗系统为 UC 患者开具生物制剂处方的频率几乎是公立医疗系统的两倍。
{"title":"HOSPITALIZATION, USE OF BIOLOGICS AND SURGERY RATES IN INFLAMMATORY BOWEL DISEASES: A SINGLE-CENTRE COMPARATIVE ANALYSIS BETWEEN PUBLIC AND PRIVATE HEALTHCARE SYSTEMS IN A TERTIARY UNIT FROM LATIN AMERICA.","authors":"Patrícia Zacharias, Daniéla Oliveira Magro, Milena Perussolo, Fernanda da Silva Barbosa Baraúna, Paulo Gustavo Kotze","doi":"10.1590/S0004-2803.24612023-140","DOIUrl":"10.1590/S0004-2803.24612023-140","url":null,"abstract":"<p><strong>Background: </strong>Inflammatory bowel diseases (IBD) have rising incidence and prevalence rates globally. In IBD, there are scarce stu-dies comparing differences between patients according to socioeconomic status. Our aim was to comparatively evaluate hospitalizations, use of biologics and rates of surgery in patients with IBD between public and private healthcare systems.</p><p><strong>Methods: </strong>Single-center retrospective cohort study in patients with IBD from a tertiary referral unit from Latin America, between 2015 and 2021. CD and UC patients were classified into two subgroups: public and private systems. Demographic characteristics, hospitalizations, need for surgery and biologics were compared.</p><p><strong>Results: </strong>A total of 500 patients were included, 322 with CD and 178 with UC. CD-related hospitalizations were frequently observed in both healthcare systems (76.28% in private and 67.46% in public). More than half of the patients had been submitted to one or more CD-related abdominal surgery, with no significant difference between the subgroups. Although there was no difference in the rates of use of biological therapy in CD subgroups, infliximab was more used in the public setting (57.69% vs 43.97%). There was no difference in UC-related hospitalizations between the subgroups (public 30.69% and private 37.66%) as well as the rates of colectomy (public: 16.83%, private: 19.48%). Biologics were prescribed almost twice as often in private as compared to public (45.45 vs 22.77%).</p><p><strong>Conclusion: </strong>There were no differences in the rates of hospitalization and abdominal surgery between the systems. In patients with UC, there was greater use of biological therapy in the private healthcare setting.</p><p><strong>Background: </strong>• In a tertiary IBD center in Latin America.</p><p><strong>Background: </strong>• More than half of the patients had been submitted to one or more CD-related abdominal surgical procedure.</p><p><strong>Background: </strong>• Between the two healthcare systems, there was no difference in the rates of use of biological therapy in patients with CD, and in UC-related hospitalizations.</p><p><strong>Background: </strong>• Biologics were prescribed almost twice as often in the private system as compared to the public in patients with UC.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e23140"},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BODY FAT COMPOSITION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A COMPARATIVE STUDY BETWEEN SKINFOLDS AND ULTRASONOGRAPHY. 炎症性肠病患者的体脂组成:皮褶和超声波检查的比较研究。
Q2 Medicine Pub Date : 2024-03-04 eCollection Date: 2024-01-01 DOI: 10.1590/S0004-2803.246102023-88
Isadora Sayuri Macedo Tuma, Maria Paula Carlin Cambi, Thyago Proença de Moraes, Daniéla Oliveira Magro, Paulo Gustavo Kotze

Background: Inflammatory bowel diseases (IBD) are associated with important changes in nutritional status.

Objective: The aim of the study was to compare body fat composition between two anthropometric methods: skinfolds and ultrasonography, in patients with IBD.

Methods: Single-center cross-sectional study with IBD patients in remission or active disease. For the agreement analysis between the body fat assessment methods, the Bland Altman method was used.

Results: A total of 101 patients with IBD were included, 75 with Crohn's disease and 26 with ulcerative colitis. Approximately 56% of the patients with Crohn's disease and 65.4% of those with ulcerative colitis had a body fat composition above normal levels, with no significant difference between the diseases (P=0.63). The Bland-Altman concordance analysis showed that the methods for assessing the percentage of fat by the adipometer and ultrasound were not in full agreement (P=0.001), despite both presented good correlation (CC 0.961; P=0.000).

Conclusion: The analysis of body fat percentage in patients with IBD was different between the skinfolds and ultrasound. Both methods can be used to assess the of body fat percentage of patients with IBD. However, monitoring of body fat sequentially and longitudinally should always be performed using the same method throughout the disease course. Prospective longitudinal studies are warranted to precisely define the role of these two methods of measuring body composition in patients with IBD.

Background: • Inflammatory bowel diseases are associated with changes in nutritional status.

Background: • Skinfolds measurements and ultrasound are valid methods for assessing body composition and body fat.

Background: • These methods despite comparable are not identical and are useful in clinical nutritional practices in IBD.

背景:炎症性肠病(IBD)与营养状况的重要变化有关:炎症性肠病(IBD)与营养状况的重要变化有关:本研究旨在比较两种人体测量方法(皮褶和超声波)在 IBD 患者体内的脂肪组成:方法:对处于缓解期或活动期的 IBD 患者进行单中心横断面研究。采用布兰德-阿尔特曼(Bland Altman)方法对两种体脂评估方法的一致性进行分析:共纳入 101 名 IBD 患者,其中 75 人为克罗恩病患者,26 人为溃疡性结肠炎患者。约 56% 的克罗恩病患者和 65.4% 的溃疡性结肠炎患者体内脂肪成分高于正常水平,疾病间无显著差异(P=0.63)。布兰德-阿尔特曼一致性分析表明,脂肪测量仪和超声波评估脂肪百分比的方法并不完全一致(P=0.001),尽管两者都呈现出良好的相关性(CC 0.961;P=0.000):结论:皮褶法和超声波法对IBD患者体内脂肪百分比的分析结果不同。这两种方法都可用于评估 IBD 患者的体脂率。然而,在整个病程中,应始终使用同一种方法对体脂进行连续和纵向监测。有必要进行前瞻性纵向研究,以准确界定这两种测量 IBD 患者身体成分的方法的作用:- 背景:炎症性肠病与营养状况的变化有关:- 背景:皮褶测量和超声波是评估身体成分和体内脂肪的有效方法:- 这些方法尽管具有可比性,但并不完全相同,在 IBD 的临床营养实践中都很有用。
{"title":"BODY FAT COMPOSITION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A COMPARATIVE STUDY BETWEEN SKINFOLDS AND ULTRASONOGRAPHY.","authors":"Isadora Sayuri Macedo Tuma, Maria Paula Carlin Cambi, Thyago Proença de Moraes, Daniéla Oliveira Magro, Paulo Gustavo Kotze","doi":"10.1590/S0004-2803.246102023-88","DOIUrl":"10.1590/S0004-2803.246102023-88","url":null,"abstract":"<p><strong>Background: </strong>Inflammatory bowel diseases (IBD) are associated with important changes in nutritional status.</p><p><strong>Objective: </strong>The aim of the study was to compare body fat composition between two anthropometric methods: skinfolds and ultrasonography, in patients with IBD.</p><p><strong>Methods: </strong>Single-center cross-sectional study with IBD patients in remission or active disease. For the agreement analysis between the body fat assessment methods, the Bland Altman method was used.</p><p><strong>Results: </strong>A total of 101 patients with IBD were included, 75 with Crohn's disease and 26 with ulcerative colitis. Approximately 56% of the patients with Crohn's disease and 65.4% of those with ulcerative colitis had a body fat composition above normal levels, with no significant difference between the diseases (P=0.63). The Bland-Altman concordance analysis showed that the methods for assessing the percentage of fat by the adipometer and ultrasound were not in full agreement (P=0.001), despite both presented good correlation (CC 0.961; P=0.000).</p><p><strong>Conclusion: </strong>The analysis of body fat percentage in patients with IBD was different between the skinfolds and ultrasound. Both methods can be used to assess the of body fat percentage of patients with IBD. However, monitoring of body fat sequentially and longitudinally should always be performed using the same method throughout the disease course. Prospective longitudinal studies are warranted to precisely define the role of these two methods of measuring body composition in patients with IBD.</p><p><strong>Background: </strong>• Inflammatory bowel diseases are associated with changes in nutritional status.</p><p><strong>Background: </strong>• Skinfolds measurements and ultrasound are valid methods for assessing body composition and body fat.</p><p><strong>Background: </strong>• These methods despite comparable are not identical and are useful in clinical nutritional practices in IBD.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e23088"},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ENDOSONOGRAPHY-GUIDED RESCUE PROCEDURES AFTER FAILED ERCP IN A PATIENT WITH PANCREATIC DUCTAL ADENOCARCINOMA. 胰腺导管腺癌患者胰管造影术失败后在内窥镜引导下进行的抢救程序。
Q2 Medicine Pub Date : 2024-03-04 eCollection Date: 2024-01-01 DOI: 10.1590/S0004-2803.24612023-152
José Celso Ardengh, Anna Carolina Orsini-Arman, Bruna Haueisen-Figueiredo, Guilherme Camarotti de Oliveira-Canejo, Otávio Micelli-Neto

Background: • The ERCP even when done by experienced professionals, fails in 10% of cases.

Background: • Until the development of the EUS-BD, PTBD had a role as a rescue therapy, despite a high rate of adverse events.

Background: • The EUS-BD is safe and has similar efficacy, when compared to PTBD and should be performed immediately after ERCP failure.

Background: • A doctor with skills in both methods (ERCP/EUS) is needed to determine the best EUS-guided therapeutic option.

背景:即使由经验丰富的专业人员进行ERCP检查,也有10%的病例会失败:- 背景:即使由经验丰富的专业人员进行ERCP检查,也有10%的病例会失败:- 背景:在 EUS-BD 出现之前,PTBD 尽管不良反应发生率较高,但仍可作为一种抢救疗法:- EUS-BD与PTBD相比安全且疗效相似,应在ERCP失败后立即进行:- 背景:需要一名同时掌握两种方法(ERCP/EUS)的医生来确定 EUS 引导下的最佳治疗方案。
{"title":"ENDOSONOGRAPHY-GUIDED RESCUE PROCEDURES AFTER FAILED ERCP IN A PATIENT WITH PANCREATIC DUCTAL ADENOCARCINOMA.","authors":"José Celso Ardengh, Anna Carolina Orsini-Arman, Bruna Haueisen-Figueiredo, Guilherme Camarotti de Oliveira-Canejo, Otávio Micelli-Neto","doi":"10.1590/S0004-2803.24612023-152","DOIUrl":"10.1590/S0004-2803.24612023-152","url":null,"abstract":"<p><strong>Background: </strong>• The ERCP even when done by experienced professionals, fails in 10% of cases.</p><p><strong>Background: </strong>• Until the development of the EUS-BD, PTBD had a role as a rescue therapy, despite a high rate of adverse events.</p><p><strong>Background: </strong>• The EUS-BD is safe and has similar efficacy, when compared to PTBD and should be performed immediately after ERCP failure.</p><p><strong>Background: </strong>• A doctor with skills in both methods (ERCP/EUS) is needed to determine the best EUS-guided therapeutic option.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e23152"},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HELICOBACTER PYLORI OIPA VIRULENCE GENE AS A MOLECULAR MARKER OF SEVERE GASTROPATHIES. 幽门螺旋杆菌 OIPA 毒力基因作为严重胃病的分子标记。
Q2 Medicine Pub Date : 2024-03-04 eCollection Date: 2024-01-01 DOI: 10.1590/S0004-2803.24612023-110
Diogo Nery Maciel, Lucas Luiz de Lima Silva, Leandro do Prado Assunção, Lucas Trevizani Rasmussen, Mônica Santiago Barbosa

Background: Helicobacter pylori is an etiologic agent of gastroduodenal diseases. The microorganism, considered a type I carcinogen, affects about 50% of the global population. H. pylori virulence factors are determinant for the clinical outcome of the infection. The outer inflammatory protein A (oipA) gene encodes an outer membrane adhesin and is related to severe gastropathies, such as gastric cancer.

Objective: The aim of this study was to evaluate the association of the oipA gene with the severity of gastroduodenal diseases in dyspeptic patients in region Central Brazil.

Methods: The polymerase chain reaction (PCR) was used to determine the presence of H. pylori. Samples positives were used for molecular screening of the oipA gene. Gastropathies were categorized as non-severe and severe diseases.

Results: Approximately 68% of patients had H. pylori and 36% were infected with H. pylori oipA+ strains. Infection was significantly associated in patients aged over 44 years (P=0.004). However, there was no association between oipA and patients' age (P=0.89). Approximately 46% of patients infected with oipA+ strains had some severe illness. Gastric adenocarcinoma was the most frequent severe gastropathy. The H. pylori oipA genotype was inversely associated with the severity of gastroduodenal diseases (OR=0.247, 95%CI: 0.0804-0.7149 and P=0.007).

Conclusion: The characterization of possible molecular markers will contribute to personalized medicine, impacting the prognosis of patients.

Background: • Evidence points to an association between the H. pylori oipA gene and gastropathies.

Background: • There is a high prevalence of H. pylori infection with a relevant percentage of oipA+ strains.

Background: • More severe gastropathies were observed in those infected with H. pylori oipA+ strains.

背景:幽门螺杆菌是胃十二指肠疾病的病原体:幽门螺杆菌是胃十二指肠疾病的病原体之一。幽门螺杆菌被认为是一种 I 型致癌物,影响着全球约 50% 的人口。幽门螺杆菌的毒力因子对感染的临床结果起着决定性作用。外炎蛋白 A(oipA)基因编码一种外膜粘附蛋白,与胃癌等严重胃病有关:本研究旨在评估 oipA 基因与巴西中部地区消化不良患者胃十二指肠疾病严重程度的相关性:聚合酶链反应(PCR)用于确定幽门螺杆菌的存在。阳性样本用于 oipA 基因的分子筛选。胃病分为非严重和严重疾病:结果:约 68% 的患者感染了幽门螺杆菌,36% 的患者感染了幽门螺杆菌 oipA+ 菌株。年龄超过 44 岁的患者感染幽门螺杆菌的几率明显增加(P=0.004)。然而,oipA 与患者的年龄并无关联(P=0.89)。在感染了 oipA+ 菌株的患者中,约 46% 的人患有某种严重疾病。胃腺癌是最常见的严重胃病。幽门螺杆菌 oipA 基因型与胃十二指肠疾病的严重程度成反比(OR=0.247,95%CI:0.0804-0.7149,P=0.007):结论:可能的分子标记物的特征将有助于个性化医疗,影响患者的预后:- 背景:有证据表明幽门螺杆菌 oipA 基因与胃病之间存在关联:- 背景:幽门螺杆菌感染率很高,其中 oipA+ 菌株占相关比例:- 幽门螺杆菌 oipA+ 菌株感染者的胃病更为严重。
{"title":"HELICOBACTER PYLORI OIPA VIRULENCE GENE AS A MOLECULAR MARKER OF SEVERE GASTROPATHIES.","authors":"Diogo Nery Maciel, Lucas Luiz de Lima Silva, Leandro do Prado Assunção, Lucas Trevizani Rasmussen, Mônica Santiago Barbosa","doi":"10.1590/S0004-2803.24612023-110","DOIUrl":"10.1590/S0004-2803.24612023-110","url":null,"abstract":"<p><strong>Background: </strong>Helicobacter pylori is an etiologic agent of gastroduodenal diseases. The microorganism, considered a type I carcinogen, affects about 50% of the global population. H. pylori virulence factors are determinant for the clinical outcome of the infection. The outer inflammatory protein A (oipA) gene encodes an outer membrane adhesin and is related to severe gastropathies, such as gastric cancer.</p><p><strong>Objective: </strong>The aim of this study was to evaluate the association of the oipA gene with the severity of gastroduodenal diseases in dyspeptic patients in region Central Brazil.</p><p><strong>Methods: </strong>The polymerase chain reaction (PCR) was used to determine the presence of H. pylori. Samples positives were used for molecular screening of the oipA gene. Gastropathies were categorized as non-severe and severe diseases.</p><p><strong>Results: </strong>Approximately 68% of patients had H. pylori and 36% were infected with H. pylori oipA+ strains. Infection was significantly associated in patients aged over 44 years (P=0.004). However, there was no association between oipA and patients' age (P=0.89). Approximately 46% of patients infected with oipA+ strains had some severe illness. Gastric adenocarcinoma was the most frequent severe gastropathy. The H. pylori oipA genotype was inversely associated with the severity of gastroduodenal diseases (OR=0.247, 95%CI: 0.0804-0.7149 and P=0.007).</p><p><strong>Conclusion: </strong>The characterization of possible molecular markers will contribute to personalized medicine, impacting the prognosis of patients.</p><p><strong>Background: </strong>• Evidence points to an association between the H. pylori oipA gene and gastropathies.</p><p><strong>Background: </strong>• There is a high prevalence of H. pylori infection with a relevant percentage of oipA+ strains.</p><p><strong>Background: </strong>• More severe gastropathies were observed in those infected with H. pylori oipA+ strains.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e23110"},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EARLY STAGES OF COLORECTAL CANCER CHARACTERIZATION BY AUTOFLUORESCENCE 3D MICROSCOPY: A PRELIMINARY STUDY. 通过自发荧光 3d 显微镜鉴定结直肠癌的早期阶段:初步研究。
Q2 Medicine Pub Date : 2024-03-04 eCollection Date: 2024-01-01 DOI: 10.1590/S0004-2803.246102023-62
Luciana Ariadna Erbes, Víctor Hugo Casco, Javier Adur

Background: Colorectal cancer is one of the most prevalent pathologies worldwide whose prognosis is linked to early detection. Colonoscopy is the gold standard for screening, and diagnosis is usually made histologically from biopsies. Aiming to reduce the inspection and diagnostic time as well as the biopsies and resources involved, other techniques are being promoted to conduct accurate in vivo colonoscopy assessments. Optical biopsy aims to detect normal and neoplastic tissues analysing the autofluorescence spectrum based on the changes in the distribution and concentration of autofluorescent molecules caused by colorectal cancer. Therefore, the autofluorescence contribution analysed by image processing techniques could be an approach to a faster characterization of the target tissue.

Objective: Quantify intensity parameters through digital processing of two data sets of three-dimensional widefield autofluorescence microscopy images, acquired by fresh colon tissue samples from a colorectal cancer murine model. Additionally, analyse the autofluorescence data to provide a characterization over a volume of approximately 50 µm of the colon mucosa for each image, at second (2nd), fourth (4th) and eighth (8th) weeks after colorectal cancer induction.

Methods: Development of a colorectal cancer murine model using azoxymethane/dextran sodium sulphate induction, and data sets acquisition of Z-stack images by widefield autofluorescence microscopy, from control and colorectal cancer induced animals. Pre-processing steps of intensity value adjustments followed by quantification and characterization procedures using image processing workflow automation by Fiji's macros, and statistical data analysis.

Results: The effectiveness of the colorectal cancer induction model was corroborated by a histological assessment to correlate and validate the link between histological and autofluorescence changes. The image digital processing methodology proposed was then performed on the three-dimensional images from control mice and from the 2nd, 4th, and 8th weeks after colorectal cancer chemical induction, for each data set. Statistical analyses found significant differences in the mean, standard deviation, and minimum parameters between control samples and those of the 2nd week after induction with respect to the 4th week of the first experimental study. This suggests that the characteristics of colorectal cancer can be detected after the 2nd week post-induction.

Conclusion: The use of autofluorescence still exhibits levels of variability that prevent greater systematization of the data obtained during the progression of colorectal cancer. However, these preliminary outcomes could be considered an approach to the three-dimensional characterization of the autofluorescence of colorectal tissue, describing the autofluorescence features of samples coming from dysp

背景:结直肠癌是全球最常见的病症之一,其预后与早期发现有关。结肠镜检查是筛查的黄金标准,通常通过活检进行组织学诊断。为了缩短检查和诊断时间,减少活检和相关资源,目前正在推广其他技术,以进行准确的体内结肠镜评估。光学活检的目的是根据大肠癌引起的自发荧光分子分布和浓度变化,通过分析自发荧光光谱来检测正常组织和肿瘤组织。因此,通过图像处理技术分析自发荧光的贡献可以更快地确定目标组织的特征:目的:通过数字处理两组三维宽域自发荧光显微镜图像数据,量化强度参数。此外,在诱发结直肠癌后的第二(2nd)、第四(4th)和第八(8th)周,分析自发荧光数据,为每张图像提供约 50 µm 的结肠粘膜体积特征:方法:利用偶氮甲烷/葡聚糖硫酸钠诱导建立小鼠结直肠癌模型,并通过宽场自发荧光显微镜采集对照组和诱发结直肠癌动物的 Z 叠图像数据集。预处理步骤包括调整强度值,然后使用 Fiji 宏进行图像处理工作流程自动化,并进行数据统计分析:结果:通过组织学评估证实了结直肠癌诱导模型的有效性,从而关联并验证了组织学和自发荧光变化之间的联系。然后,针对每组数据,对对照组小鼠和结直肠癌化学诱导后第 2、4 和 8 周的小鼠的三维图像进行了图像数字处理。统计分析发现,对照组样本和诱导后第 2 周样本的平均值、标准偏差和最小参数与第一次实验研究的第 4 周样本相比有显著差异。这表明,诱导后第 2 周后即可检测出结直肠癌的特征:结论:自发荧光的使用仍存在一定程度的可变性,这妨碍了在结直肠癌发展过程中获得更系统化的数据。然而,这些初步结果可被视为结直肠组织自发荧光三维特征的一种方法,描述了从发育不良到结直肠癌样本的自发荧光特征:- 背景:开发了一种新的数字图像处理方法,利用 CRC 小鼠模型测量结直肠样本三维自发荧光图像的强度:- 背景:该方法显示,结肠粘膜的自发荧光强度与健康组织相似,但在肿瘤发展过程中会发生显著变化:- 统计分析显示,从诱导后第二周开始就能检测到 CRC 特征,有助于早期发现 CRC:- 该研究为结肠直肠组织从发育不良到癌症的三维自发荧光特征描述提供了基础,但自发荧光的变化限制了癌症进展过程中数据的系统化。
{"title":"EARLY STAGES OF COLORECTAL CANCER CHARACTERIZATION BY AUTOFLUORESCENCE 3D MICROSCOPY: A PRELIMINARY STUDY.","authors":"Luciana Ariadna Erbes, Víctor Hugo Casco, Javier Adur","doi":"10.1590/S0004-2803.246102023-62","DOIUrl":"10.1590/S0004-2803.246102023-62","url":null,"abstract":"<p><strong>Background: </strong>Colorectal cancer is one of the most prevalent pathologies worldwide whose prognosis is linked to early detection. Colonoscopy is the gold standard for screening, and diagnosis is usually made histologically from biopsies. Aiming to reduce the inspection and diagnostic time as well as the biopsies and resources involved, other techniques are being promoted to conduct accurate in vivo colonoscopy assessments. Optical biopsy aims to detect normal and neoplastic tissues analysing the autofluorescence spectrum based on the changes in the distribution and concentration of autofluorescent molecules caused by colorectal cancer. Therefore, the autofluorescence contribution analysed by image processing techniques could be an approach to a faster characterization of the target tissue.</p><p><strong>Objective: </strong>Quantify intensity parameters through digital processing of two data sets of three-dimensional widefield autofluorescence microscopy images, acquired by fresh colon tissue samples from a colorectal cancer murine model. Additionally, analyse the autofluorescence data to provide a characterization over a volume of approximately 50 µm of the colon mucosa for each image, at second (2nd), fourth (4th) and eighth (8th) weeks after colorectal cancer induction.</p><p><strong>Methods: </strong>Development of a colorectal cancer murine model using azoxymethane/dextran sodium sulphate induction, and data sets acquisition of Z-stack images by widefield autofluorescence microscopy, from control and colorectal cancer induced animals. Pre-processing steps of intensity value adjustments followed by quantification and characterization procedures using image processing workflow automation by Fiji's macros, and statistical data analysis.</p><p><strong>Results: </strong>The effectiveness of the colorectal cancer induction model was corroborated by a histological assessment to correlate and validate the link between histological and autofluorescence changes. The image digital processing methodology proposed was then performed on the three-dimensional images from control mice and from the 2nd, 4th, and 8th weeks after colorectal cancer chemical induction, for each data set. Statistical analyses found significant differences in the mean, standard deviation, and minimum parameters between control samples and those of the 2nd week after induction with respect to the 4th week of the first experimental study. This suggests that the characteristics of colorectal cancer can be detected after the 2nd week post-induction.</p><p><strong>Conclusion: </strong>The use of autofluorescence still exhibits levels of variability that prevent greater systematization of the data obtained during the progression of colorectal cancer. However, these preliminary outcomes could be considered an approach to the three-dimensional characterization of the autofluorescence of colorectal tissue, describing the autofluorescence features of samples coming from dysp","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e23062"},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PREDICTORS OF FAILURE OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN CLEARING BILE DUCT STONES DURING INDEX PROCEDURE - A PROSPECTIVE STUDY. 内镜逆行胰胆管造影术清除胆管结石失败的预测因素 - 一项前瞻性研究。
Q2 Medicine Pub Date : 2024-03-04 eCollection Date: 2024-01-01 DOI: 10.1590/S0004-2803.24612023-112
Abhishek Kamuni, Lohith Kumar, Suprabhat Giri, Sumaswi Angadi, Sunil Kumar Nanjegowda, Sukanya Bhrugumalla

Background: Common bile duct (CBD) stones are known to complicate 10-15% of gallstone diseases. Endoscopic retrograde cholangiopancreatography (ERCP) is the therapeutic modality of choice for bile duct clearance in CBD stones but may fail to achieve stone clearance. This prospective study was done to identify the predictors of failure of CBD clearance with ERCP.

Objective: This prospective study was done to identify the predictors of failure of CBD clearance with ERCP.

Methods: All consecutive patients with bile duct stones undergoing ERCP at a tertiary care center were prospectively included from October 2020 to October 2021. The study's primary outcome was to identify and analyze factors that could predict the failure of complete CBD clearance.

Results: A total of 120 patients (50.8% males, median age: 53.5 years) were included in the final analysis. Successful clearance of CBD stones during the index procedure was achieved in 70% of patients. At a cut-off stone diameter of >10.5 mm and CBD diameter of >12.5 mm, the AUC was 0.890 and 0.884, respectively, to predict failed clearance of CBD. On multivariate analysis, stone diameter ≥15 mm [odds ratio (OR) 16.97, 95% confidence interval (CI): 1.629-176.785], location of stones in hepatic ducts (OR 7.74, 95%CI: 2.041-29.332), presence of stricture distal to stone (OR 6.99, 95%CI: 1.402-34.726) and impacted stone (OR 21.61, 95%CI: 1.84-253.058) were independent predictors of failed bile duct clearance.

Conclusion: Stone size and location are independent predictors of failed bile duct clearance. The endoscopist should consider these factors while subjecting a patient to biliary ductal clearance to plan additional intervention.

Background: • Failure to clear bile duct stones in the index ERCP can be seen in 15-20% of cases, and identifying the factors associated with failure is important.

Background: • A prospective analysis was conducted to identify and analyze the factors that could predict the failure of complete CBD clearance.

Background: • The present study reported a successful clearance of CBD stones during the index procedure in only 70% of patients.

Background: • A stone diameter ≥15 mm, location of stones in hepatic ducts, presence of stricture distal to stone, and impacted stone were independent predictors of failed bile duct clearance.

背景:据了解,胆总管(CBD)结石并发症占胆石症的10%-15%。内镜逆行胰胆管造影术(ERCP)是胆总管结石患者进行胆管清石的首选治疗方式,但可能无法实现结石清除。这项前瞻性研究旨在确定ERCP清除CBD结石失败的预测因素:这项前瞻性研究旨在确定ERCP清除CBD结石失败的预测因素:2020年10月至2021年10月期间,在一家三级医疗中心接受ERCP治疗的所有胆管结石患者均被纳入前瞻性研究。研究的主要结果是确定并分析可预测胆总管结石完全清除失败的因素:共有120名患者(50.8%为男性,中位年龄:53.5岁)被纳入最终分析。70%的患者在指数手术中成功清除了CBD结石。以结石直径大于 10.5 毫米和 CBD 直径大于 12.5 毫米为临界值,预测 CBD 清除失败的 AUC 分别为 0.890 和 0.884。在多变量分析中,结石直径≥15 mm [几率比(OR)16.97,95% 置信区间(CI):1.629-176.785]、结石位置在肝管(OR 7.74,95%CI:2.041-29.332)、结石远端存在狭窄(OR 6.99,95%CI:1.402-34.726)和结石撞击(OR 21.61,95%CI:1.84-253.058)是胆管清理失败的独立预测因素:结论:结石大小和位置是胆管清理失败的独立预测因素。结论:结石大小和位置是胆管清理失败的独立预测因素,内镜医师在对患者进行胆管清理时应考虑这些因素,以制定额外的干预计划:- 背景:15%-20%的病例在ERCP检查中未能清除胆管结石,确定与失败相关的因素非常重要:- 一项前瞻性分析旨在确定和分析可预测CBD完全清除失败的因素:- 本研究报告称,仅有70%的患者在索引手术中成功清除了CBD结石:- 结石直径≥15毫米、结石位于肝管、结石远端存在狭窄以及结石撞击是胆管清除失败的独立预测因素。
{"title":"PREDICTORS OF FAILURE OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN CLEARING BILE DUCT STONES DURING INDEX PROCEDURE - A PROSPECTIVE STUDY.","authors":"Abhishek Kamuni, Lohith Kumar, Suprabhat Giri, Sumaswi Angadi, Sunil Kumar Nanjegowda, Sukanya Bhrugumalla","doi":"10.1590/S0004-2803.24612023-112","DOIUrl":"10.1590/S0004-2803.24612023-112","url":null,"abstract":"<p><strong>Background: </strong>Common bile duct (CBD) stones are known to complicate 10-15% of gallstone diseases. Endoscopic retrograde cholangiopancreatography (ERCP) is the therapeutic modality of choice for bile duct clearance in CBD stones but may fail to achieve stone clearance. This prospective study was done to identify the predictors of failure of CBD clearance with ERCP.</p><p><strong>Objective: </strong>This prospective study was done to identify the predictors of failure of CBD clearance with ERCP.</p><p><strong>Methods: </strong>All consecutive patients with bile duct stones undergoing ERCP at a tertiary care center were prospectively included from October 2020 to October 2021. The study's primary outcome was to identify and analyze factors that could predict the failure of complete CBD clearance.</p><p><strong>Results: </strong>A total of 120 patients (50.8% males, median age: 53.5 years) were included in the final analysis. Successful clearance of CBD stones during the index procedure was achieved in 70% of patients. At a cut-off stone diameter of >10.5 mm and CBD diameter of >12.5 mm, the AUC was 0.890 and 0.884, respectively, to predict failed clearance of CBD. On multivariate analysis, stone diameter ≥15 mm [odds ratio (OR) 16.97, 95% confidence interval (CI): 1.629-176.785], location of stones in hepatic ducts (OR 7.74, 95%CI: 2.041-29.332), presence of stricture distal to stone (OR 6.99, 95%CI: 1.402-34.726) and impacted stone (OR 21.61, 95%CI: 1.84-253.058) were independent predictors of failed bile duct clearance.</p><p><strong>Conclusion: </strong>Stone size and location are independent predictors of failed bile duct clearance. The endoscopist should consider these factors while subjecting a patient to biliary ductal clearance to plan additional intervention.</p><p><strong>Background: </strong>• Failure to clear bile duct stones in the index ERCP can be seen in 15-20% of cases, and identifying the factors associated with failure is important.</p><p><strong>Background: </strong>• A prospective analysis was conducted to identify and analyze the factors that could predict the failure of complete CBD clearance.</p><p><strong>Background: </strong>• The present study reported a successful clearance of CBD stones during the index procedure in only 70% of patients.</p><p><strong>Background: </strong>• A stone diameter ≥15 mm, location of stones in hepatic ducts, presence of stricture distal to stone, and impacted stone were independent predictors of failed bile duct clearance.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e23112"},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EVALUATING LACTOFERRIN AND CALPROTECTIN AS MARKERS OF INTESTINAL INFLAMMATION INCHRONIC PANCREATITIS. 评估作为慢性胰腺炎肠道炎症标志物的乳铁蛋白和钙蛋白。
Q2 Medicine Pub Date : 2024-03-04 eCollection Date: 2024-01-01 DOI: 10.1590/S0004-2803.246102024-03
Claudia Teresa Carvente, Maria Lúcia Cardoso Gomes Ferraz, Carlos Fischer de Toledo

Background: The treatment of chronic pancreatitis does not consistently solve intestinal abnormalities, and despite the implementation of various therapeutic measures, patients often continue to experience persistent diarrhea. Therefore, it is imperative to recognize that diarrhea may stem from factors beyond pancreatic insufficiency, and intestinal inflammation emerges as a potential contributing factor.

Objective: The aim of this study was to assess fecal lactoferrin and calprotectin levels as indicators of intestinal inflammation in patients with chronic pancreatitis experiencing persistent diarrhea.

Methods: In this study, 23 male patients with chronic pancreatitis primarily attributed to alcohol consumption and presenting with diarrhea (classified as Bristol stool scale type 6 or 7), underwent a comprehensive evaluation of their clinical and nutritional status. Fecal lactoferrin and calprotectin levels were mea-sured utilizing immunoassay techniques.

Results: The average age of the participants was 54.8 years, 43.5% had diabetes, and 73.9% were smokers. Despite receiving enzyme replacement therapy and refraining from alcohol for over 4 years, all participants exhibited persistent diarrhea, accompanied by elevated calprotectin and lactoferrin levels indicative of ongoing intestinal inflammation.

Conclusion: The findings of this study underscore that intestinal inflammation, as evidenced by elevated fecal biomarkers calprotectin and lactoferrin, may contribute to explaining the persistence of diarrhea in patients with chronic pancreatitis.

Background: • Exploration of intestinal inflammation in chronic pancreatitis patients with altered bowel habits.

Background: • Assessment of 23 patients using lactoferrin and calprotectin as intestinal inflammation biomarkers.

Background: • Intestinal inflammation was detected in all patients; positive correlation between both biomarkers.

Background: • Established connection between altered bowel habits and intestinal inflammation in chronic pancreatitis.

背景:慢性胰腺炎的治疗并不能一成不变地解决肠道异常问题,尽管采取了各种治疗措施,但患者往往仍会持续腹泻。因此,必须认识到腹泻可能源于胰腺功能不全以外的因素,而肠道炎症则是一个潜在的诱因:本研究的目的是评估慢性胰腺炎患者的粪便乳铁蛋白和钙粘蛋白水平,作为持续腹泻患者肠道炎症的指标:在这项研究中,23 名主要因饮酒导致慢性胰腺炎并伴有腹泻(布里斯托粪便量表 6 型或 7 型)的男性患者接受了临床和营养状况综合评估。利用免疫测定技术测定了粪便乳铁蛋白和钙粘蛋白水平:参与者的平均年龄为 54.8 岁,43.5% 的人患有糖尿病,73.9% 的人吸烟。尽管接受了酶替代疗法并戒酒 4 年多,但所有参与者都表现出持续腹泻,同时伴有钙蛋白和乳铁蛋白水平升高,表明肠道炎症仍在持续:本研究的结果强调,粪便生物标志物钙蛋白和乳铁蛋白升高所显示的肠道炎症可能是慢性胰腺炎患者持续腹泻的原因之一:- 探究排便习惯改变的慢性胰腺炎患者的肠道炎症:- 使用乳铁蛋白和钙粘蛋白作为肠道炎症生物标志物对23名患者进行评估:- 所有患者均检测到肠道炎症;两种生物标志物之间呈正相关:- 慢性胰腺炎患者肠道习惯改变与肠道炎症之间的联系已被证实。
{"title":"EVALUATING LACTOFERRIN AND CALPROTECTIN AS MARKERS OF INTESTINAL INFLAMMATION INCHRONIC PANCREATITIS.","authors":"Claudia Teresa Carvente, Maria Lúcia Cardoso Gomes Ferraz, Carlos Fischer de Toledo","doi":"10.1590/S0004-2803.246102024-03","DOIUrl":"10.1590/S0004-2803.246102024-03","url":null,"abstract":"<p><strong>Background: </strong>The treatment of chronic pancreatitis does not consistently solve intestinal abnormalities, and despite the implementation of various therapeutic measures, patients often continue to experience persistent diarrhea. Therefore, it is imperative to recognize that diarrhea may stem from factors beyond pancreatic insufficiency, and intestinal inflammation emerges as a potential contributing factor.</p><p><strong>Objective: </strong>The aim of this study was to assess fecal lactoferrin and calprotectin levels as indicators of intestinal inflammation in patients with chronic pancreatitis experiencing persistent diarrhea.</p><p><strong>Methods: </strong>In this study, 23 male patients with chronic pancreatitis primarily attributed to alcohol consumption and presenting with diarrhea (classified as Bristol stool scale type 6 or 7), underwent a comprehensive evaluation of their clinical and nutritional status. Fecal lactoferrin and calprotectin levels were mea-sured utilizing immunoassay techniques.</p><p><strong>Results: </strong>The average age of the participants was 54.8 years, 43.5% had diabetes, and 73.9% were smokers. Despite receiving enzyme replacement therapy and refraining from alcohol for over 4 years, all participants exhibited persistent diarrhea, accompanied by elevated calprotectin and lactoferrin levels indicative of ongoing intestinal inflammation.</p><p><strong>Conclusion: </strong>The findings of this study underscore that intestinal inflammation, as evidenced by elevated fecal biomarkers calprotectin and lactoferrin, may contribute to explaining the persistence of diarrhea in patients with chronic pancreatitis.</p><p><strong>Background: </strong>• Exploration of intestinal inflammation in chronic pancreatitis patients with altered bowel habits.</p><p><strong>Background: </strong>• Assessment of 23 patients using lactoferrin and calprotectin as intestinal inflammation biomarkers.</p><p><strong>Background: </strong>• Intestinal inflammation was detected in all patients; positive correlation between both biomarkers.</p><p><strong>Background: </strong>• Established connection between altered bowel habits and intestinal inflammation in chronic pancreatitis.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e24003"},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ASSESSMENT OF THE ACCURACY OF THE RAPID TEST FOR THE DIAGNOSIS OF HELICOBACTER PYLORI IN PATIENTS THAT DIDN'T UNDERGO PREVIOUS ERADICATION THERAPY AND WHO WENT THROUGH ENDOSCOPY. 对未接受过根除治疗和内窥镜检查的患者进行幽门螺旋杆菌快速检测的准确性评估。
Q2 Medicine Pub Date : 2024-03-04 eCollection Date: 2024-01-01 DOI: 10.1590/S0004-2803.24612023-136
Gianluca Z Rovaris, João V Back, Maria Paula Ronchi-Colombo, Vitória S Rosa, Manoel C B Cardoso, Emilio C Berger

Background: Helicobacter pylori infection is widely spread globally and is known to cause potentially serious diseases. Several diagnostic methods exist to identify and treat carriers of this bacterium. Serological tests for the diagnosis of infection are based on the detection of antibodies immunoglobulin G against H. pylori, a non-invasive, inexpensive, and easy-to-perform option.

Objective: This research aims to ascertain the accuracy of an immunochromatographic serological test to verify the feasibility of using this method in patients who have not undergone previous eradication therapy.

Methods: Rapid tests and questionnaires were applied to 53 patients that underwent upper digestive endoscopy with research for H. pylori between the period of September and October 2021. The results were compared with histopathology.

Results: In the rapid tests, seven positive and 46 negative results were obtained. When compared with the gold stan-dard, the following values were described: sensitivity 54.5%, specificity 97.6%, positive predictive value 85.7%, and negative predictive value 89.1%.

Conclusion: In the present study, the immunochromatographic serological tests had an accuracy close to the values found in other similar studies. Therefore, it may be concluded that the rapid serological test remains a reasonable choice for screening large populations due to its low cost and ease of application, especially in those individuals who have not undergone previous treatment.

Background: • Helicobacter pylori infection can cause potentially serious diseases.

Background: • Serological tests are based on the detection of antibodies immunoglobulin G against Helicobacter pylori.

Background: • Serological tests for the diagnosis of Helicobacter pylori infection are low cost tools and have easy application.

Background: • Rapid serological test is a reasonable choice for screening large populations.

背景:幽门螺杆菌感染在全球广泛传播,已知可导致潜在的严重疾病。目前有几种诊断方法可以识别和治疗这种细菌的携带者。诊断感染的血清学检验基于检测针对幽门螺杆菌的免疫球蛋白 G 抗体,这是一种无创、廉价且易于操作的方法:本研究旨在确定免疫层析血清学检测的准确性,以验证在未接受过根除治疗的患者中使用这种方法的可行性:方法:在 2021 年 9 月至 10 月期间,对 53 名接受上消化道内窥镜检查的患者进行了幽门螺杆菌快速检测和问卷调查。结果与组织病理学结果进行了比较:结果:在快速检测中,共获得 7 项阳性结果和 46 项阴性结果。与金标准相比,结果显示:灵敏度为 54.5%,特异性为 97.6%,阳性预测值为 85.7%,阴性预测值为 89.1%:在本研究中,免疫层析血清学检测的准确性接近于其他类似研究中发现的数值。因此,可以得出结论,快速血清学检测因其成本低、应用简便,仍然是筛查大量人群的合理选择,尤其是那些未接受过治疗的人群:- 背景:幽门螺杆菌感染可导致潜在的严重疾病:- 血清学检测的基础是检测针对幽门螺旋杆菌的免疫球蛋白 G 抗体:- 背景:诊断幽门螺旋杆菌感染的血清学试验是一种低成本的工具,易于应用:- 背景:快速血清学检测是筛查大量人群的合理选择。
{"title":"ASSESSMENT OF THE ACCURACY OF THE RAPID TEST FOR THE DIAGNOSIS OF HELICOBACTER PYLORI IN PATIENTS THAT DIDN'T UNDERGO PREVIOUS ERADICATION THERAPY AND WHO WENT THROUGH ENDOSCOPY.","authors":"Gianluca Z Rovaris, João V Back, Maria Paula Ronchi-Colombo, Vitória S Rosa, Manoel C B Cardoso, Emilio C Berger","doi":"10.1590/S0004-2803.24612023-136","DOIUrl":"10.1590/S0004-2803.24612023-136","url":null,"abstract":"<p><strong>Background: </strong>Helicobacter pylori infection is widely spread globally and is known to cause potentially serious diseases. Several diagnostic methods exist to identify and treat carriers of this bacterium. Serological tests for the diagnosis of infection are based on the detection of antibodies immunoglobulin G against H. pylori, a non-invasive, inexpensive, and easy-to-perform option.</p><p><strong>Objective: </strong>This research aims to ascertain the accuracy of an immunochromatographic serological test to verify the feasibility of using this method in patients who have not undergone previous eradication therapy.</p><p><strong>Methods: </strong>Rapid tests and questionnaires were applied to 53 patients that underwent upper digestive endoscopy with research for H. pylori between the period of September and October 2021. The results were compared with histopathology.</p><p><strong>Results: </strong>In the rapid tests, seven positive and 46 negative results were obtained. When compared with the gold stan-dard, the following values were described: sensitivity 54.5%, specificity 97.6%, positive predictive value 85.7%, and negative predictive value 89.1%.</p><p><strong>Conclusion: </strong>In the present study, the immunochromatographic serological tests had an accuracy close to the values found in other similar studies. Therefore, it may be concluded that the rapid serological test remains a reasonable choice for screening large populations due to its low cost and ease of application, especially in those individuals who have not undergone previous treatment.</p><p><strong>Background: </strong>• Helicobacter pylori infection can cause potentially serious diseases.</p><p><strong>Background: </strong>• Serological tests are based on the detection of antibodies immunoglobulin G against Helicobacter pylori.</p><p><strong>Background: </strong>• Serological tests for the diagnosis of Helicobacter pylori infection are low cost tools and have easy application.</p><p><strong>Background: </strong>• Rapid serological test is a reasonable choice for screening large populations.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e23136"},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
INFLUENCE OF NEOADJUVANT THERAPY ON THE RATIO OF LYMPH NODES. 新辅助治疗对淋巴结比例的影响。
Q2 Medicine Pub Date : 2024-03-04 eCollection Date: 2024-01-01 DOI: 10.1590/S0004-2803.24612023-131
Laura Credidio, Carlos Augusto Real Martinez, Daniéla Oliveira Magro, Rita Barbosa de Carvalho, Maria de Lourdes Setsuko Ayrizono, Cláudio Saddy Rodrigues Coy

Background: To evaluate the relationship between the ratio of affected lymph nodes (LNR) and clinical and anatomopathological variables in patients with rectal adenocarcinoma submitted or not to neoadjuvant chemoradiotherapy.

Methods: The LNR was determined by dividing the number of compromised LNR by the total number of LNR dissected in the surgical specimen. Patients were divided into two groups: with QRT and without QRT. In each group, the relationship between LNR and the following variables was evaluated: degree of cell differentiation, depth of invasion in the rectal wall, angiolymphatic /perineural invasion, degree of tumor regression and occurrence of metastases. The LNR was evaluated in patients with more than 1, LNR (LNR >12) or less (LNR<12) in the surgical specimen with overall survival (OS) and disease-free survival (DFS). The results were expressed as the mean with the respective standard deviation. Qualitative variables were analyzed using Fisher's exact test, while quantitative variables were analyzed using the Kruskal -Wallis and Mann-Whitney tests. The significance level was 5%.

Results: We evaluated 282 patients with QRT and 114 without QRT, between 1995-2011. In the QRT Group, LNR showed a significant association with mucinous tumors (P=0.007) and degree of tumor regression (P=0.003). In both groups, LNR was associated with poorly differentiated tumors (P=0.001, P=0.02), presence of angiolymphatic invasion (P<0.0001 and P=0.01), perineural (P=0.0007, P=0.02), degree of rectal wall invasion (T3>T2; P<0.0001, P=0.02); Compromised LNR (P<0.0001, P<0.01), metastases (P<0.0001, P<0.01). In patients with QRT, LNR<12 was associated with DFS (5.889; 95%CI1.935-19.687; P=0.018) and LNR>12 with DFS and OS (17.984; 95%CI5.931-54.351; P<0.001 and 10.286; 95%CI 2.654-39.854; P=0.007, respectively).

Conclusion: LNR was associated with histological aspects of poor prognosis, regardless of the use of QRT. In the occurrence of less than 12 evaluated LNR, the LNR was associated only with the DFS.

Background: • Assessment of the lymph nodes during pathological analysis of the surgical specimen is crucial to determine treatment and prognosis.

Background: • Neoadjuvance therapy reduces the number of lymph nodes, being lower than recommended, therefore the lymph node ratio can be an alternative analysis for a better prognosis.

研究背景目的:评估接受或未接受新辅助化放疗的直肠腺癌患者受累淋巴结(LNR)比例与临床和解剖病理变量之间的关系:LNR是用受损LNR的数量除以手术标本中解剖的LNR总数得出的。患者分为两组:接受 QRT 和未接受 QRT。在每组中,评估 LNR 与以下变量之间的关系:细胞分化程度、直肠壁侵犯深度、血管淋巴/神经外膜侵犯、肿瘤消退程度和转移发生率。对 LNR 超过 1 个(LNR >12)或低于 1 个(LNR 结果:我们对 1995-2011 年间 282 名接受 QRT 和 114 名未接受 QRT 的患者进行了评估。在QRT组中,LNR与粘液性肿瘤(P=0.007)和肿瘤消退程度(P=0.003)有显著相关性。在两组中,LNR与分化不良肿瘤(P=0.001,P=0.02)、血管淋巴浸润(PT2;P12与DFS和OS(17.984;95%CI5.931-54.351;PConclusion)相关:无论是否使用 QRT,LNR 都与预后不良的组织学因素有关。在发生少于 12 个经评估的 LNR 的情况下,LNR 仅与 DFS 相关:- 背景:在对手术标本进行病理分析时,淋巴结的评估对于确定治疗和预后至关重要:- 背景:新辅助治疗减少了淋巴结的数量,低于推荐值,因此淋巴结比值可作为一种替代分析方法,以获得更好的预后。
{"title":"INFLUENCE OF NEOADJUVANT THERAPY ON THE RATIO OF LYMPH NODES.","authors":"Laura Credidio, Carlos Augusto Real Martinez, Daniéla Oliveira Magro, Rita Barbosa de Carvalho, Maria de Lourdes Setsuko Ayrizono, Cláudio Saddy Rodrigues Coy","doi":"10.1590/S0004-2803.24612023-131","DOIUrl":"10.1590/S0004-2803.24612023-131","url":null,"abstract":"<p><strong>Background: </strong>To evaluate the relationship between the ratio of affected lymph nodes (LNR) and clinical and anatomopathological variables in patients with rectal adenocarcinoma submitted or not to neoadjuvant chemoradiotherapy.</p><p><strong>Methods: </strong>The LNR was determined by dividing the number of compromised LNR by the total number of LNR dissected in the surgical specimen. Patients were divided into two groups: with QRT and without QRT. In each group, the relationship between LNR and the following variables was evaluated: degree of cell differentiation, depth of invasion in the rectal wall, angiolymphatic /perineural invasion, degree of tumor regression and occurrence of metastases. The LNR was evaluated in patients with more than 1, LNR (LNR >12) or less (LNR<12) in the surgical specimen with overall survival (OS) and disease-free survival (DFS). The results were expressed as the mean with the respective standard deviation. Qualitative variables were analyzed using Fisher's exact test, while quantitative variables were analyzed using the Kruskal -Wallis and Mann-Whitney tests. The significance level was 5%.</p><p><strong>Results: </strong>We evaluated 282 patients with QRT and 114 without QRT, between 1995-2011. In the QRT Group, LNR showed a significant association with mucinous tumors (P=0.007) and degree of tumor regression (P=0.003). In both groups, LNR was associated with poorly differentiated tumors (P=0.001, P=0.02), presence of angiolymphatic invasion (P<0.0001 and P=0.01), perineural (P=0.0007, P=0.02), degree of rectal wall invasion (T3>T2; P<0.0001, P=0.02); Compromised LNR (P<0.0001, P<0.01), metastases (P<0.0001, P<0.01). In patients with QRT, LNR<12 was associated with DFS (5.889; 95%CI1.935-19.687; P=0.018) and LNR>12 with DFS and OS (17.984; 95%CI5.931-54.351; P<0.001 and 10.286; 95%CI 2.654-39.854; P=0.007, respectively).</p><p><strong>Conclusion: </strong>LNR was associated with histological aspects of poor prognosis, regardless of the use of QRT. In the occurrence of less than 12 evaluated LNR, the LNR was associated only with the DFS.</p><p><strong>Background: </strong>• Assessment of the lymph nodes during pathological analysis of the surgical specimen is crucial to determine treatment and prognosis.</p><p><strong>Background: </strong>• Neoadjuvance therapy reduces the number of lymph nodes, being lower than recommended, therefore the lymph node ratio can be an alternative analysis for a better prognosis.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e23131"},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Arquivos de Gastroenterologia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1